RhumbLine Advisers’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.6M | Buy |
323,371
+3,187
| +1% | +$794K | 0.06% | 258 |
|
|
2025
Q4 | $77.1M | Buy |
320,184
+1,247
| +0.4% | +$319K | 0.06% | 248 |
|
|
2025
Q3 | $87.3M | Buy |
318,937
+11,696
| +4% | +$3.19M | 0.07% | 230 |
|
|
2025
Q2 | $79.3M | Buy |
307,241
+782
| +0.3% | +$187K | 0.07% | 244 |
|
|
2025
Q1 | $68.6M | Buy |
306,459
+11,324
| +4% | +$2.64M | 0.06% | 256 |
|
|
2024
Q4 | $67.5M | Sell |
295,135
-13,536
| -4% | -$3.26M | 0.06% | 259 |
|
|
2024
Q3 | $75.4M | Sell |
308,671
-2,946
| -0.9% | -$658K | 0.07% | 243 |
|
|
2024
Q2 | $59.6M | Sell |
311,617
-18,772
| -6% | -$3.81M | 0.06% | 281 |
|
|
2024
Q1 | $65.4M | Sell |
330,389
-2,316
| -0.7% | -$424K | 0.06% | 269 |
|
|
2023
Q4 | $57.2M | Sell |
332,705
-2,041
| -0.6% | -$314K | 0.06% | 281 |
|
|
2023
Q3 | $49.5M | Sell |
334,746
-13,070
| -4% | -$2.36M | 0.06% | 285 |
|
|
2023
Q2 | $76M | Buy |
347,816
+6,930
| +2% | +$1.54M | 0.09% | 212 |
|
|
2023
Q1 | $74.7M | Buy |
340,886
+17,389
| +5% | +$3.77M | 0.09% | 204 |
|
|
2022
Q4 | $67.3M | Buy |
323,497
+18,652
| +6% | +$4.1M | 0.09% | 211 |
|
|
2022
Q3 | $66.5M | Buy |
304,845
+25,957
| +9% | +$5.91M | 0.1% | 185 |
|
|
2022
Q2 | $58.5M | Buy |
278,888
+12,546
| +5% | +$2.67M | 0.09% | 212 |
|
|
2022
Q1 | $64.6M | Sell |
266,342
-16,821
| -6% | -$4.07M | 0.08% | 211 |
|
|
2021
Q4 | $73.8M | Sell |
283,163
-7,176
| -2% | -$1.86M | 0.09% | 193 |
|
|
2021
Q3 | $76.5M | Sell |
290,339
-11,482
| -4% | -$3.14M | 0.1% | 168 |
|
|
2021
Q2 | $74.4M | Sell |
301,821
-16,553
| -5% | -$3.48M | 0.1% | 174 |
|
|
2021
Q1 | $61.8M | Sell |
318,374
-20,000
| -6% | -$4.01M | 0.08% | 206 |
|
|
2020
Q4 | $71.9M | Sell |
338,374
-36,646
| -10% | -$7.31M | 0.1% | 169 |
|
|
2020
Q3 | $64.3M | Sell |
375,020
-26,976
| -7% | -$4.98M | 0.1% | 171 |
|
|
2020
Q2 | $77.2M | Buy |
401,996
+11,143
| +3% | +$1.82M | 0.13% | 145 |
|
|
2020
Q1 | $57.6M | Buy |
390,853
+27,175
| +7% | +$4.33M | 0.12% | 159 |
|
|
2019
Q4 | $56.4M | Buy |
363,678
+20,142
| +6% | +$2.9M | 0.09% | 201 |
|
|
2019
Q3 | $46.4M | Sell |
343,536
-903
| -0.3% | -$118K | 0.08% | 219 |
|
|
2019
Q2 | $42M | Buy |
344,439
+17,284
| +5% | +$1.91M | 0.08% | 226 |
|
|
2019
Q1 | $34M | Sell |
327,155
-9,912
| -3% | -$1.02M | 0.07% | 263 |
|
|
2018
Q4 | $38.4M | Sell |
337,067
-11,829
| -3% | -$1.27M | 0.08% | 219 |
|
|
2018
Q3 | $40.2M | Sell |
348,896
-4,218
| -1% | -$462K | 0.08% | 247 |
|
|
2018
Q2 | $36.6M | Buy |
353,114
+5,227
| +2% | +$529K | 0.07% | 264 |
|
|
2018
Q1 | $34.3M | Sell |
347,887
-7,723
| -2% | -$730K | 0.07% | 274 |
|
|
2017
Q4 | $30.1M | Sell |
355,610
-5,310
| -1% | -$439K | 0.06% | 309 |
|
|
2017
Q3 | $27.8M | Sell |
360,920
-12,371
| -3% | -$946K | 0.06% | 313 |
|
|
2017
Q2 | $29.1M | Sell |
373,291
-2,400
| -0.6% | -$172K | 0.07% | 302 |
|
|
2017
Q1 | $27M | Buy |
375,691
+15,971
| +4% | +$1.1M | 0.06% | 315 |
|
|
2016
Q4 | $22.3M | Buy |
359,720
+34,684
| +11% | +$2.12M | 0.06% | 347 |
|
|
2016
Q3 | $21.1M | Buy |
325,036
+17,039
| +6% | +$1.13M | 0.06% | 321 |
|
|
2016
Q2 | $19.5M | Buy |
307,997
+5,408
| +2% | +$319K | 0.06% | 331 |
|
|
2016
Q1 | $17.5M | Sell |
302,589
-7,430
| -2% | -$421K | 0.05% | 339 |
|
|
2015
Q4 | $16.6M | Buy |
310,019
+2,868
| +0.9% | +$162K | 0.05% | 343 |
|
|
2015
Q3 | $15.7M | Buy |
307,151
+10,723
| +4% | +$577K | 0.05% | 354 |
|
|
2015
Q2 | $16.7M | Buy |
296,428
+25,131
| +9% | +$1.59M | 0.05% | 352 |
|
|
2015
Q1 | $19.5M | Buy |
271,297
+14,044
| +5% | +$912K | 0.06% | 304 |
|
|
2014
Q4 | $14.4M | Sell |
257,253
-1,100
| -0.4% | -$57.4K | 0.04% | 386 |
|
|
2014
Q3 | $12.7M | Sell |
258,353
-4,883
| -2% | -$249K | 0.04% | 413 |
|
|
2014
Q2 | $13.3M | Sell |
263,236
-29,972
| -10% | -$1.49M | 0.04% | 412 |
|
|
2014
Q1 | $13.1M | Sell |
293,208
-2,501
| -0.8% | -$112K | 0.04% | 406 |
|
|
2013
Q4 | $13.9M | Sell |
295,709
-16,517
| -5% | -$836K | 0.04% | 384 |
|
|
2013
Q3 | $16.5M | Buy |
312,226
+55,663
| +22% | +$2.7M | 0.05% | 344 |
|
|
2013
Q2 | $11.6M | Buy |
+256,563
| New | +$12.2M | 0.04% | 422 |
|
Other funds holding RMD
VCM
VPM
DAM
RhumbLine Advisers's RMD Position: Q1 2026 in Review
RhumbLine Advisers increased its ResMed (RMD) stake by 1% in Q1 2026, buying an estimated $794K and bringing the position to 323,371 shares worth $72.6M. The position accounts for 0.06% of the portfolio, ranked #258.
RhumbLine Advisers first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.3M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- RhumbLine Advisers held 323,371 shares of ResMed worth $72.6M as of Q1 2026.
- RhumbLine Advisers bought 3,187 ResMed shares in Q1 2026, an estimated $794K.
- ResMed made up 0.06% of RhumbLine Advisers's portfolio in Q1 2026, its #258 holding.
- RhumbLine Advisers first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's ResMed position peaked at $87.3M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.